An article published Nov. 19 about Baxter International Inc.'s agreement to purchase North American Vaccine Inc. of Columbia stated that North American Vaccine's chief executive officer, Randal Chase, would receive a bonus as a result of the sale. The article failed to note that under his compensation plan, Chase is entitled to a bonus only if North American Vaccine is sold for at least $20 a share. North American is being sold for $7 a share; therefore, a bonus for Chase is not guaranteed.
The Sun regrets the omission.
Pub Date: 11/23/99
